Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin transporter gene polymorphism study in hyperlipidemia
IRCT20221127056625N1Phase 4Completed
- Sponsor
- National University of Medical Sciences
- Start
- Dec 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of rosuvastatin in hyperlipidemia, sponsored by National University of Medical Sciences. Primary endpoints: Polymorphic alleles of rosuvastatin transporter genes SLCO1B3 and ABCG2, Plasma rosuvastatin levels and 5 more. Started Dec 2022; status: completed.
02
Drugs
rosuvastatin
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on IRCT20221127056625N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221127056625N1.